Claremont Creek Ventures Company Profile

Background

Claremont Creek Ventures (CCV) is a venture capital firm established in 2005 and headquartered in Oakland, California. The firm specializes in seed and early-stage investments, focusing on companies that provide innovative digital solutions to essential, broad-impact industries. CCV's mission is to enhance efficiency and create new high-growth, high-margin businesses through strategic investments. The firm practices "life cycle venturing," establishing in-depth, active relationships with entrepreneurs alongside or even ahead of early-stage funding events. CCV has invested in over 40 companies, including notable firms such as Clean Power Finance, EcoATM, and Natera.

Key Strategic Focus

CCV's strategic focus encompasses investments in sectors where information technology drives significant advancements. The firm targets industries such as digital healthcare, energy technology, payments and commerce, and online businesses. By leveraging its deep domain expertise, CCV aims to identify and support companies that offer innovative solutions capable of transforming these sectors. The firm's "life cycle venturing" approach involves mentoring startups prior to investment, assisting founders in refining product development, go-to-market strategies, making key hires, and closing initial deals.

Financials and Funding

CCV manages more than $300 million across two funds. The firm's investment style is entrepreneur-friendly and aimed at building value over the long term. CCV typically invests between $500,000 to $3.5 million in Series A rounds, with substantial reserves to support subsequent funding rounds. Institutional limited partners, including Harvard Management Company, the Regents of the University of California, and the Verizon Pension Fund, have shown confidence in CCV's strategy by investing in the firm's funds.

Pipeline Development

CCV's portfolio includes companies at various stages of development across multiple sectors. Notable investments include:

Natera: A diagnostic company specializing in genetic testing services, primarily focused on preconception and prenatal testing. Natera's flagship product, Panorama, is a non-invasive prenatal test that screens for chromosomal abnormalities in fetuses through a blood draw from the mother. The company has also developed Signatera, a technology that detects circulating tumor DNA to monitor cancer recurrence.

EcoATM: A company specializing in the recycling of electronic devices, including cell phones, tablets, and MP3 players, through automated kiosks located throughout the United States. EcoATM provides a convenient platform for consumers to sell unwanted electronics, offering cash on the spot for devices they no longer use.

Assurex Health: A personalized medicine company dedicated to helping clinicians determine the right medication for individual patients with medical conditions. Assurex Health's proprietary GeneSight technology is based on pharmacogenomics, the study of genetic factors that influence an individual's response to drug treatments.

Technological Platform and Innovation

CCV's portfolio companies leverage advanced technological platforms and innovative methodologies to differentiate themselves in their respective industries. For instance:

NuMedii: Utilizes proprietary Big Data technology to predict which drugs will be most effective in treating particular diseases. The technology integrates vast amounts of life sciences data with network-based algorithms to discover drug-disease connections and biomarkers predictive of efficacy.

DNAnexus: Provides cloud-based genome informatics and data management tools aimed at enterprises engaged in genomic medicine. The company's platform enables the analysis and management of genomic data in the cloud, facilitating research and clinical applications.

Leadership Team

CCV's leadership team comprises experienced professionals with diverse backgrounds:

Nathaniel Goldhaber: Co-Founder and Managing Director. Goldhaber has a background in energy technology and has been involved in various entrepreneurial ventures.

Randy Hawks: Managing Director. Hawks has experience in information technology and has been involved in multiple successful investments.

Ted Driscoll: Technology Partner. Driscoll brings expertise in digital healthcare and has been instrumental in guiding CCV's investments in this sector.

Bradford C. Webb: Venture Partner. Webb has a background in energy technology and contributes to CCV's strategic focus in this area.

Leadership Changes

There have been no recent significant changes or appointments within CCV's leadership team.

Competitor Profile

Market Insights and Dynamics

The venture capital industry is highly competitive, with numerous firms vying to invest in promising startups across various sectors. The market is characterized by rapid technological advancements, evolving consumer preferences, and a constant influx of new entrepreneurs seeking funding.

Competitor Analysis

CCV operates in a competitive landscape alongside other venture capital firms that focus on early-stage investments in technology-driven companies. Key competitors include:

Lightspeed Venture Partners: A global venture capital firm with over $2 billion of committed capital under management. Lightspeed has backed more than 200 companies, many of which have become leaders in their respective markets.

Sequoia Capital: A venture capital firm known for investing in early-stage companies across various sectors, including technology, healthcare, and energy.

Andreessen Horowitz: A venture capital firm that invests in technology companies at various stages, from seed to late-stage.

Strategic Collaborations and Partnerships

CCV collaborates with various institutions to strengthen its market position and innovation capacity. The firm works closely with local universities such as UC Berkeley and UC Davis, as well as the Lawrence Livermore and Berkeley Laboratories. These collaborations provide CCV with access to cutting-edge research and emerging technologies, enhancing its ability to identify and support promising startups.

Operational Insights

CCV's strategic considerations in relation to major competitors involve leveraging its "life cycle venturing" approach to establish deep relationships with entrepreneurs early in their development. This proactive engagement allows CCV to provide value beyond capital, including mentorship and strategic guidance, which differentiates the firm from competitors. Additionally, CCV's focus on sectors where information technology drives significant advancements enables the firm to identify and invest in companies with high growth potential.

Strategic Opportunities and Future Directions

Looking ahead, CCV aims to continue its focus on investing in companies that offer innovative digital solutions to essential industries. The firm plans to leverage its existing relationships with research institutions and its "life cycle venturing" approach to identify and support startups with the potential to transform their respective sectors. By maintaining its commitment to building long-term value and supporting entrepreneurs beyond capital investment, CCV is well-positioned to capitalize on emerging opportunities in the venture capital landscape.